Director Lymphoma Research
Sarah Cannon Research Institute, Tennessee Oncology
Nashville, Tennessee
Ian W. Flinn, MD, PhD. is the Director of Lymphoma Research at the Sarah Cannon Research Institute. In this role, he oversees lymphoma research throughout Sarah Cannon and its affiliates. Dr. Flinn also serves as the Director for the Sarah Cannon Center for Blood Cancer at Tennessee Oncology. Dr. Flinn’s research focuses on the development of new therapies for patients with lymphoma and chronic lymphocytic leukemia. This research includes first in human to phase 3 trials with novel approaches such as immune effector cell therapies, inhibitors of the B cell receptor pathway, and BCL-2 inhibitors amongst others. His research has been widely published in journals such as the New England Journal of Medicine, Lancet, Journal of Clinical Oncology and Blood.
Disclosure information not submitted.
Wednesday, May 11, 2022
1:30 PM – 2:55 PM
Wednesday, May 11, 2022
2:15 PM – 2:35 PM
Wednesday, May 11, 2022
2:35 PM – 2:55 PM